(2R)-2-Ethyloxirane, 97.0%, 5g

3-(Pyridin-4-yl)propyl benzoate, 1g

4-(5-Methyl-furan-2-yl)-thiazol-2-ylamine, 95.0%, 5g

GC capillary column ROTI®Cap-5, 50 m, 0.25 mm, 1.00 µm, 1 Piece(s)

(5S,8S,10aR)-3-((Benzyloxy)carbonyl)-5-((tert-butoxycarbonyl)amino)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxylic acid, 97%, 250mg

2-(3-(Methylsulfonamido)phenyl)acetic acid, 95.0%, 1g

Methyl morpholine-2-carboxylate hydrochloride, 95.0%, 1g

1-Boc-5-Aminoindole, 95.0%, 100g

4-Bromo-2-fluoro-6-methylbenzoic acid, 95.0%, 25g

4-Bromo-2-(trifluoromethyl)benzaldehyde, 95.0%, 100g

Catalpol, 99.98%, 1g

4,6-Dichloro-2-methanesulfonylpyrimidine, 97.0%, 10g

3,4,5,6,7,8-Hexahydroquinolin-2(1H)-one, 98%, 1g